Study Details

Study ID 1941-CL-0016
Study Title A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Multiple Dose Study to Assess the Safety and Tolerability of ASP1941 in Adult Patients with Type 2 Diabetes Mellitus Identifier NCT00790660
Compound Name ASP1941 / ipragliflozin
Medical Indication or Disease Type 2 diabetes mellitus
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 23-Oct-2008
Study Completion Date 06-Mar-2009
Clinical Study Result
Select the language
Plain Language Summary
Select the language